Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs
Abstract Background In the era of second-generation ALK tyrosine kinase inhibitors (ALK-TKIs), there was a paucity of data regarding the progression patterns, resistant mechanisms, and subsequent therapeutic approaches for ALK-positive (ALK+) non-small cell lung cancer (NSCLC). Methods Patients with...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-06-01
|
| Серія: | Journal of Translational Medicine |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s12967-024-05388-0 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|